Literature DB >> 23609791

Recommendations for the investigation of animal models of Prader-Willi syndrome.

James L Resnick1, Robert D Nicholls, Rachel Wevrick.   

Abstract

Prader-Willi syndrome (PWS) occurs in about 1 in 15,000 individuals and is a contiguous gene disorder causing developmental disability, hyperphagia usually with obesity, and behavioral problems, including an increased incidence of psychiatric illness. The genomic imprinting that regulates allele-specific expression of PWS candidate genes, the fact that multiple genes are typically inactivated, and the presence of many genes that produce functional RNAs rather than proteins has complicated the identification of the underlying genetic pathophysiology of PWS. Over 30 genetically modified mouse strains that have been developed and characterized have been instrumental in elucidating the genetic and epigenetic mechanisms for the regulation of PWS genes and in discovering their physiological functions. In 2011, a PWS Animal Models Working Group (AMWG) was established to generate discussions and facilitate exchange of ideas regarding the best use of PWS animal models. Here, we summarize the goals of the AMWG, describe current animal models of PWS, and make recommendations for strategies to maximize the utility of animal models and for the development and use of new animal models of PWS.

Entities:  

Mesh:

Year:  2013        PMID: 23609791     DOI: 10.1007/s00335-013-9454-2

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  97 in total

1.  DNA demethylation reactivation of imprinted genes in cell lines from patients with Prader-Willi syndrome and a mouse model.

Authors:  Kyoko Takano; Maki Okajima; Shinji Saitoh
Journal:  Am J Med Genet A       Date:  2007-06-15       Impact factor: 2.802

2.  Retrotransposed genes such as Frat3 in the mouse Chromosome 7C Prader-Willi syndrome region acquire the imprinted status of their insertion site.

Authors:  J H Chai; D P Locke; T Ohta; J M Greally; R D Nicholls
Journal:  Mamm Genome       Date:  2001-11       Impact factor: 2.957

3.  Maternal methylation imprints on human chromosome 15 are established during or after fertilization.

Authors:  O El-Maarri; K Buiting; E G Peery; P M Kroisel; B Balaban; K Wagner; B Urman; J Heyd; C Lich; C I Brannan; J Walter; B Horsthemke
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

4.  Hormonal and metabolic defects in a prader-willi syndrome mouse model with neonatal failure to thrive.

Authors:  M Stefan; H Ji; R A Simmons; D E Cummings; R S Ahima; M I Friedman; R D Nicholls
Journal:  Endocrinology       Date:  2005-07-07       Impact factor: 4.736

5.  A guide to analysis of mouse energy metabolism.

Authors:  Matthias H Tschöp; John R Speakman; Jonathan R S Arch; Johan Auwerx; Jens C Brüning; Lawrence Chan; Robert H Eckel; Robert V Farese; Jose E Galgani; Catherine Hambly; Mark A Herman; Tamas L Horvath; Barbara B Kahn; Sara C Kozma; Eleftheria Maratos-Flier; Timo D Müller; Heike Münzberg; Paul T Pfluger; Leona Plum; Marc L Reitman; Kamal Rahmouni; Gerald I Shulman; George Thomas; C Ronald Kahn; Eric Ravussin
Journal:  Nat Methods       Date:  2011-12-28       Impact factor: 28.547

Review 6.  Neurobehavioral phenotype in Prader-Willi syndrome.

Authors:  Joyce Whittington; Anthony Holland
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-11-15       Impact factor: 3.908

7.  Induced pluripotent stem cells can be used to model the genomic imprinting disorder Prader-Willi syndrome.

Authors:  Jiayin Yang; Jie Cai; Ya Zhang; Xianming Wang; Wen Li; Jianyong Xu; Feng Li; Xiangpeng Guo; Kang Deng; Mei Zhong; Yonglong Chen; Liangxue Lai; Duanqing Pei; Miguel A Esteban
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

8.  Necdin plays a role in the serotonergic modulation of the mouse respiratory network: implication for Prader-Willi syndrome.

Authors:  Sébastien Zanella; Françoise Watrin; Saïda Mebarek; Fabienne Marly; Michel Roussel; Catherine Gire; Gwenaëlle Diene; Maïté Tauber; Françoise Muscatelli; Gérard Hilaire
Journal:  J Neurosci       Date:  2008-02-13       Impact factor: 6.167

9.  Identification of a novel paternally expressed gene in the Prader-Willi syndrome region.

Authors:  R Wevrick; J A Kerns; U Francke
Journal:  Hum Mol Genet       Date:  1994-10       Impact factor: 6.150

10.  Necdin protects embryonic motoneurons from programmed cell death.

Authors:  Julianne Aebischer; Rachel Sturny; David Andrieu; Anne Rieusset; Fabienne Schaller; Sandrine Geib; Cédric Raoul; Françoise Muscatelli
Journal:  PLoS One       Date:  2011-09-02       Impact factor: 3.240

View more
  22 in total

1.  Sleeve gastrectomy leads to weight loss in the Magel2 knockout mouse.

Authors:  Deanna M Arble; Joshua W Pressler; Joyce Sorrell; Rachel Wevrick; Darleen A Sandoval
Journal:  Surg Obes Relat Dis       Date:  2016-04-27       Impact factor: 4.734

2.  Ube3a imprinting impairs circadian robustness in Angelman syndrome models.

Authors:  Shu-qun Shi; Terry Jo Bichell; Rebecca A Ihrie; Carl Hirschie Johnson
Journal:  Curr Biol       Date:  2015-02-05       Impact factor: 10.834

3.  Dysfunctional oleoylethanolamide signaling in a mouse model of Prader-Willi syndrome.

Authors:  Miki Igarashi; Vidya Narayanaswami; Virginia Kimonis; Pietro M Galassetti; Fariba Oveisi; Kwang-Mook Jung; Daniele Piomelli
Journal:  Pharmacol Res       Date:  2016-12-19       Impact factor: 7.658

4.  Magel2 knockout mice manifest altered social phenotypes and a deficit in preference for social novelty.

Authors:  M D Fountain; H Tao; C-A Chen; J Yin; C P Schaaf
Journal:  Genes Brain Behav       Date:  2017-04-04       Impact factor: 3.449

Review 5.  Epigenetic therapy of Prader-Willi syndrome.

Authors:  Yuna Kim; Sung Eun Wang; Yong-Hui Jiang
Journal:  Transl Res       Date:  2019-03-05       Impact factor: 7.012

6.  Hypothalamic loss of Snord116 and Prader-Willi syndrome hyperphagia: the buck stops here?

Authors:  Juan A Rodriguez; Jeffrey M Zigman
Journal:  J Clin Invest       Date:  2018-01-29       Impact factor: 14.808

7.  Magel2-null mice are hyper-responsive to setmelanotide, a melanocortin 4 receptor agonist.

Authors:  Jocelyn M Bischof; Lex H T Van Der Ploeg; William F Colmers; Rachel Wevrick
Journal:  Br J Pharmacol       Date:  2016-07-27       Impact factor: 8.739

Review 8.  The role of genomic imprinting in biology and disease: an expanding view.

Authors:  Jo Peters
Journal:  Nat Rev Genet       Date:  2014-06-24       Impact factor: 53.242

9.  Ghrelin Receptor Agonist Rescues Excess Neonatal Mortality in a Prader-Willi Syndrome Mouse Model.

Authors:  Juan A Rodriguez; Emily C Bruggeman; Bharath K Mani; Sherri Osborne-Lawrence; Caleb C Lord; Henry F Roseman; Hannah L Viroslav; Prasanna Vijayaraghavan; Nathan P Metzger; Deepali Gupta; Kripa Shankar; Claudio Pietra; Chen Liu; Jeffrey M Zigman
Journal:  Endocrinology       Date:  2018-12-01       Impact factor: 4.736

10.  Deletion of the Snord116/SNORD116 Alters Sleep in Mice and Patients with Prader-Willi Syndrome.

Authors:  Glenda Lassi; Lorenzo Priano; Silvia Maggi; Celina Garcia-Garcia; Edoardo Balzani; Nadia El-Assawy; Marco Pagani; Federico Tinarelli; Daniela Giardino; Alessandro Mauro; Jo Peters; Alessandro Gozzi; Graziano Grugni; Valter Tucci
Journal:  Sleep       Date:  2016-03-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.